Follicular psoriasis induced by pembrolizumab in a patient with advanced non-small-cell lung cancer

Int J Dermatol. 2019 Aug;58(8):e151-e152. doi: 10.1111/ijd.14457. Epub 2019 Apr 9.

Authors

Federica Scarfì¹, Rossella Lacava¹, Annalisa Patrizi¹, Federico Tartari¹, Giulia Maria Ravaioli¹, Giulia Veronesi¹, Martina Lambertini¹, Emi Dika¹

Affiliation

¹ Dermatology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.

PMID: 30964199
DOI: 10.1111/ijd.14457

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Abnormalities, Multiple / diagnosis
Aged
Antibodies, Monoclonal, Humanized / adverse effects*
Carcinoma, Non-Small-Cell Lung / drug therapy*
Carcinoma, Non-Small-Cell Lung / pathology
Darier Disease / diagnosis
Dermoscopy
Diagnosis, Differential
Eyebrows / abnormalities
Humans
Lung Neoplasms / drug therapy*
Lung Neoplasms / pathology
Male
Neoplasm Staging
Psoriasis / chemically induced*
Psoriasis / diagnostic imaging

Substances

Antibodies, Monoclonal, Humanized
pembrolizumab

Supplementary concepts

Burnett Schwartz Berberian syndrome